MEK, a crucial component of the rat sarcoma/rapidly accelerated fibrosarcoma/mitogen‐activated protein kinase kinase/extracellular signal‐regulated kinase (RAS/RAF/MEK/ERK) signaling cascade, has become a key target in cancer treatment. This evidence concerns the gene MAP2K7 and cancer.